| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/17425247.4.4.389 |
| P698 | PubMed publication ID | 17683252 |
| P50 | author | Peter L Choyke | Q90059714 |
| P2093 | author name string | Martin W Brechbiel | |
| Andrew J Gunn | |||
| P2860 | cites work | In vivo imaging of tumors with protease-activated near-infrared fluorescent probes | Q28141852 |
| Antibody-targeted radiation cancer therapy | Q28264580 | ||
| Radioimmunotherapy of small-volume disease of metastatic colorectal cancer | Q33341317 | ||
| Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results | Q33368517 | ||
| Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer | Q33372304 | ||
| Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. | Q34107863 | ||
| Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging | Q34164704 | ||
| The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases | Q34471196 | ||
| Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. | Q34543902 | ||
| In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent | Q35082675 | ||
| Molecular imaging: The latest generation of contrast agents and tissue characterization techniques | Q35549446 | ||
| Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia | Q35721975 | ||
| Antibody targeted drugs as cancer therapeutics | Q36373103 | ||
| Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies | Q36375924 | ||
| Targeted therapy of cancer: new prospects for antibodies and immunoconjugates | Q36548206 | ||
| Targeted radionuclide therapy for solid tumors: an overview | Q36595724 | ||
| Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment | Q39536084 | ||
| A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate | Q40158320 | ||
| Emerging role of platelet-derived growth factor receptor-beta inhibition in radioimmunotherapy of experimental pancreatic cancer | Q40187881 | ||
| Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model | Q40188234 | ||
| Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin | Q40244381 | ||
| Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2. | Q40358108 | ||
| Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody | Q40365972 | ||
| In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595. | Q40388290 | ||
| A calicheamicin conjugate with a fully humanized anti-MUC1 antibody shows potent antitumor effects in breast and ovarian tumor xenografts | Q40446537 | ||
| Herceptin-geldanamycin immunoconjugates: pharmacokinetics, biodistribution, and enhanced antitumor activity | Q40588168 | ||
| Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. | Q40698258 | ||
| Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach | Q40722517 | ||
| Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis | Q40890556 | ||
| Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning | Q40892824 | ||
| Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin | Q42389576 | ||
| Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatment. | Q43002836 | ||
| Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. | Q43679702 | ||
| Cytoreductive surgery combined with intraoperative chemo-hyperthermia and postoperative radiotherapy in the management of advanced pancreatic adenocarcinoma: feasibility aspects and efficacy | Q43961804 | ||
| Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents | Q43977099 | ||
| Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins | Q44538103 | ||
| Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent | Q44572339 | ||
| Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy | Q44750686 | ||
| Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft | Q44781029 | ||
| Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion | Q45288550 | ||
| Patterns and progress in ovarian cancer over 14 years | Q46494571 | ||
| 90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas | Q46519117 | ||
| Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion | Q46839317 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide. | Q53530705 | ||
| Pancreatic cancer in the general population: Improvements in survival over the last decade. | Q54438493 | ||
| Combination Therapy Using Gemcitabine and Radioimmunotherapy in Nude Mice with Small Peritoneal Metastases of Colonic Origin | Q57779503 | ||
| The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy | Q57951032 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 389-402 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Expert Opinion on Drug Delivery | Q5421203 |
| P1476 | title | The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis | |
| P478 | volume | 4 |
| Q26768312 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer and other less common disease histologies: is it time? |
| Q39300912 | Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest |
| Q53239060 | Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT. |
| Q50457607 | Imaging of 186Re-liposome therapy in ovarian cancer xenograft model of peritoneal carcinomatosis. |
| Q36983932 | Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease |
| Q38096059 | Radioimmunotherapy for peritoneal cancers |
| Q33455875 | Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells |
| Q35590698 | Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis |
Search more.